Public Pricelist
  1. All Products
  2. Biosimilar Antibodies
  3. Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

https://www.pathco.org/web/image/product.template/137783/image_1920?unique=6dd64d0
(0 review)
Connects CD19 on B-cells to CD3 on T-cells, enabling T-cell–mediated cytotoxicity. A leading tool for leukemia and lymphoma research models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.

Contact Us

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: GMA-CD19
Display Name: [GMA-CD19] Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody
Image 512: